正文：
近日，国家卫健委、教育部等14个部委联合发布了《关于印发2024年纠正医药购销领域和医疗服务中不正之风工作方案的通知》，旨在进一步加强医保基金监管，坚决打击欺诈骗保行为，确保医保基金安全有效使用。
《工作方案》明确了2024年将重点围绕医保基金使用监管、医疗服务质量提升、医药购销行为规范等方面开展工作。具体措施包括：
1. 加大医保基金监管力度，通过建立和完善医保基金监管体系，加强事前、事中和事后监管，确保医保基金的安全。
2. 加强医疗服务质量管理，推动医疗机构提升医疗服务水平，规范医疗服务行为，确保患者权益不受侵害。
3. 严格医药购销行为规范，对医药购销中的不正当竞争、虚假宣传、回扣等行为进行严厉打击，维护市场秩序。
4. 强化部门协作和信息共享，建立跨部门、跨区域的监管合作机制，形成监管合力。
此次《工作方案》的发布，体现了国家对医保基金监管的重视，以及对打击欺诈骗保行为的高压态势。通过多部门联合行动，将有效遏制医药购销领域和医疗服务中的不正之风，为人民群众提供更加安全、有效、便捷的医疗服务。
未来，14部委将继续深化改革，完善监管机制，不断提高医保基金使用效率，确保人民群众的切身利益不受损害。
英语如下：
News Title: “14 Departments Unite to Strengthen Supervision of Medical Insurance Fund, Maintain High-Pressure Crackdown on Cheating and Fraud”
Keywords: Medical Insurance Supervision, Crackdown on Cheating, Correcting Unhealthy Trends
News Content:
Title: 14 Departments Jointly Strengthen Supervision of Medical Insurance Fund, Maintain High-Pressure Crackdown on Cheating and Fraud
Article:
Recently, the National Health Commission, the Ministry of Education, and other 14 departments jointly released a notice on the “2024 Work Plan to Correct Improper Conduct in the Pharmaceutical Procurement and Medical Service Field.” The aim is to further strengthen the supervision of medical insurance funds and resolutely crack down on cheating and fraudulent behavior to ensure the safe and effective use of medical insurance funds.
The “Work Plan” outlines the focus for 2024, which includes the supervision of medical insurance fund use, the improvement of medical service quality, and the standardization of pharmaceutical procurement behavior. Specific measures include:
1. Strengthening the supervision of medical insurance funds by establishing and improving a regulatory system to ensure the safety of medical insurance funds through pre-, in-, and post-event supervision.
2. Enhancing the management of medical service quality to push medical institutions to improve their service levels and standardize service behaviors to ensure that patients’ rights are not infringed upon.
3. Strictly regulating pharmaceutical procurement behavior by severely punishing improper competition, false advertising, kickbacks, and other behaviors in pharmaceutical procurement to maintain market order.
4. Strengthening inter-departmental cooperation and information sharing to establish a regulatory cooperation mechanism across departments and regions to form a regulatory synergy.
The release of the “Work Plan” reflects the state’s seriousness in supervising medical insurance funds and its high-pressure stance against cheating and fraudulent behavior. Through joint actions by multiple departments, it will effectively curb the unhealthy trends in the pharmaceutical procurement and medical service fields, providing the people with safer, more effective, and more convenient medical services.
In the future, the 14 departments will continue to deepen reforms and improve regulatory mechanisms to enhance the efficiency of the use of medical insurance funds and ensure that the legitimate interests of the people are not harmed.
【来源】http://www.chinanews.com/gn/2024/05-27/10223852.shtml
Views: 1